South State Corp Editas Medicine, Inc. Transaction History
South State Corp
- $1.52 Billion
- Q4 2024
A detailed history of South State Corp transactions in Editas Medicine, Inc. stock. As of the latest transaction made, South State Corp holds 500 shares of EDIT stock, worth $730. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$730
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding EDIT
# of Institutions
227Shares Held
54.2MCall Options Held
412KPut Options Held
355K-
Black Rock Inc. New York, NY7.78MShares$11.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.82MShares$9.96 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.75MShares$4.01 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.16MShares$3.15 Million0.0% of portfolio
-
State Street Corp Boston, MA1.87MShares$2.73 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $100M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...